Swiss National Bank’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-6,700
Closed -$98K 2539
2017
Q3
$98K Hold
6,700
﹤0.01% 2525
2017
Q2
$701K Hold
6,700
﹤0.01% 2275
2017
Q1
$858K Sell
6,700
-733
-10% -$77.3K ﹤0.01% 2126
2016
Q4
$665K Hold
7,433
﹤0.01% 2263
2016
Q3
$546K Buy
7,433
+1,533
+26% +$111K ﹤0.01% 2319
2016
Q2
$392K Buy
5,900
+483
+9% +$27.5K ﹤0.01% 2455
2016
Q1
$253K Buy
5,417
+900
+20% +$47.7K ﹤0.01% 2528
2015
Q4
$336K Hold
4,517
﹤0.01% 2448
2015
Q3
$312K Buy
4,517
+617
+16% +$57.9K ﹤0.01% 2387
2015
Q2
$356K Buy
3,900
+1,450
+59% +$147K ﹤0.01% 2386
2015
Q1
$270K Buy
2,450
+1,083
+79% +$127K ﹤0.01% 2419
2014
Q4
$184K Buy
+1,367
New +$160K ﹤0.01% 2522

Other funds holding ARAV

Swiss National Bank's ARAV Position: Q4 2017 in Review

Swiss National Bank sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2017, closing a stake of 6,700 shares — an estimated $98K sold.

Swiss National Bank first reported a position in ARAV in Q4 2014 and held it in 12 quarters. The position peaked at $858K in Q1 2017. 85 funds tracked by Wall St. Rank hold ARAV as of Q4 2017.

  • Swiss National Bank reported no remaining Aravive, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Swiss National Bank sold 6,700 Aravive, Inc. Common Stock shares in Q4 2017, an estimated $98K.
  • Swiss National Bank first reported a position in Aravive, Inc. Common Stock in Q4 2014 and held it in 12 quarters.
  • Swiss National Bank's Aravive, Inc. Common Stock position peaked at $858K in Q1 2017.
  • 85 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2017.

Based on Swiss National Bank's 13F filing for Q4 2017, filed 7 Feb 2018.